Showing all 4 results

Show sidebar

Thalidomide-O-PEG-Propargyl Ester is a chemical compound that has been developed as an anti-cancer therapeutic agent. It is a new form of thalidomide, a pharmaceutical originally developed to treat morning sickness in pregnant women. The new compound is an ester of thalidomide and polyethylene glycol propargyl ether (PEG-PA), which is a chemical with the ability to bind to certain proteins in the body and decrease their activity. This could help reduce the growth of tumor cells in cancer patients.

Cat# Name Structure M.W. Purity Pricing
AP13003Thalidomide-O-PEG2-Propargyl400.39≥95% Pricing
AP13002Thalidomide-O-PEG3-Propargyl444.44≥95% Pricing
AP12334Thalidomide-O-PEG4-Propargyl488.49≥95% Pricing
AP12127Thalidomide-O-amido-PEG4-propargyl545.55≥95% Pricing

Bulk Inquiry